INTRODUCTION TO THE AGENUS CLASs ACTION LAWSUIT Call now for a free case evaluation in the Agenus class action lawsuit
The Agenus class action lawsuit seeks to represent purchasers or acquirers of Agenus Inc. (NASDAQ: AGEN) publicly traded securities between January 23, 2023, and July 17, 2024, inclusive (the “Class Period”). Captioned Olsen v. Agenus Inc., No. 24-cv-12299 (D. Mass.), the Agenus class action lawsuit charges Agenus and certain of Agenus’ top executives with violations of the Securities Exchange Act of 1934.
If you have suffered losses in Agenus stock and are interested in becoming the lead plaintiff in the Agenus class action lawsuit or have any inquiries regarding your rights as a shareholder, please reach out to Agenus Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact form below. Lead plaintiff motions for the Agenus class action lawsuit must be filed with the court no later than November 5, 2024. This article aims to provide an in-depth understanding of the Agenus class action lawsuit, including its background, allegations, lead plaintiff process, and potential outcomes. If you suffered losses in Agenus stock, continue reading to learn more about your rights and options. UNDERSTANDING THE Agenus CLASS ACTION LAWSUIT
The Agenus class action lawsuit, filed as Olsen v. Agenus Inc., No. 24-cv-12299 (D. Mass.), accuses Agenus and certain top executives of violating the Securities Exchange Act of 1934. The Agenus class action lawsuit alleges that throughout the Class Period, MongoDB made false and misleading statements, failed to disclose crucial information, and engaged in deceptive practices that artificially inflated the value of its stock.
If you have suffered losses in Agenus stock and are interested in becoming the lead plaintiff in the Agenus class action lawsuit or have any inquiries regarding your rights as a shareholder, please reach out to Timothy L. Miles at no cost. You can contact him by calling 855/846–6529, sending an e-mail to [email protected], or filling out a contact form. Lead plaintiff motions for the Agenus class action lawsuit must be filed with the court no later than November 5, 2024. Allegations in the Agenus Class Action Lawsuit
Agenus, a clinical-stage biotechnology company focused on immuno-oncology products, faces serious allegations in the Agenus class action lawsuit. Here are the main points:
• Misleading Statements: Defendants allegedly made false and/or misleading statements throughout the Class Period. • Overstated Efficacy: The lawsuit claims the combination therapy of botensilimab and balstilimab was less effective than investors were led to believe. • Exaggerated Results: Clinical results, regulatory prospects, and commercial potential of botensilimab and balstilimab were allegedly overstated. • FDA Setback: On July 18, 2024, Agenus revealed that the FDA advised against submitting results for Accelerated Approval, citing concerns that "objective response rates may not translate to survival benefit." • Stock Price Plummet: Following the FDA news, Agenus stock price plunged nearly 59%, devastating investors. • Specific Products in Question:
• Investor Deception: Plaintiffs argue that investors were misled about the true potential of Agenus' key product candidates. • Regulatory Hurdles: The FDA's advice against submission for Accelerated Approval raises questions about the company's regulatory strategy. • Financial Impact: The dramatic stock price drop highlights the significant financial consequences of the alleged misrepresentations. The Benefits of Serving as a Lead Plaintiff in the Agenus Class Action Lawsuit
Lead Plaintiff Deadline and Class Membership Give Timothy L. Miles a call today about the Agenus class action lawsuit
Lead plaintiff motions for the Agenus class action lawsuit must be filed with the court no later than November 5, 2024. It is essential to file a motion to be appointed as lead plaintiff within this timeframe to actively participate in the lawsuit. However, even if an investor misses the lead plaintiff deadline, they will still be considered a class member and entitled to share in any potential settlement or recovery.
To determine class membership, an investor must have purchased Agenus stock during the class period, which spans from January 23, 2023, to July 17, 2024, and suffered losses. If an investor purchases shares outside of this period, they will not be able to participate in the Agenus class action lawsuit. OPTIONS FOR CLASS MEMBERS IN THE AGENUS LAWSUIT
As a class member in the Agenus class action lawsuit, you have two primary options:
STAGES OF THE CLASS ACTION AGAINST Agenus
HIRING An Agenus STOCK LOSS LAWYER
If you suffered losses in Agenus stock and wish to pursue legal action, it is crucial to consult with an experienced Agenus stock loss lawyer. A skilled attorney experienced in securities fraud can guide you through the complex legal process, protect your rights, and advocate for your interests. They will have in-depth knowledge of securities laws, extensive experience in class action lawsuits, and the resources to effectively represent your case.
One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021). This will most likely be the only call you need to make. (855) 846–6529 or [email protected] CONCLUSION
The Agenus class action lawsuit presents an opportunity for investors who suffered losses in Agenus stock to seek justice and recover their damages. By understanding the allegations, lead plaintiff process, and potential outcomes, investors can make informed decisions about their legal options. If you suffered losses in Agenus stock, consult with an experienced Agenus stock loss lawyer like Timothy L. Miles to evaluate your case and determine the best course of action. (855) 846–6529 or [email protected].
Remember, time is of the essence, as the lead plaintiff deadline approaches. Take the necessary steps to protect your rights and hold Agenus accountable for any alleged securities fraud. CONTACT Agenus STOCK LOSS LAWYER TODAY TIMOTHY L MILES TODAY ABOUT An Agenus CLASS ACTION LAWSUIT
If you suffered losses in Agenus stock, contact Agenus stock loss lawyer Timothy L. Miles today for a free case evaluation about a Agenus class action lawsuit. Call today and see what an Agenus stock loss lawyer could do for you if you suffered losses in Agenus stock. This will most likely be the only call you need to make. (855) 846–6529 or [email protected].
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846–6529 Email: [email protected] Agenus stock loss lawyer Timothy L. Miles Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
HoursSITEMAP
|
|
